Benefit of Elevation of HDL-C in Women

Completed · Phase 4 · Has a placebo group

Conditions studied: Cardiovascular Outcomes

In brief

The combination of HDL-C elevation, lowering of triglycerides and further LDL-C reduction accomplished by the addition of niacin to statin medication would improve endothelial function as compared to LDL-C reduction alone in patients with and without coronary artery disease and the combination of low HDL-C/high triglycerides. The combination of lipid lowering therapy would have beneficial effects on markers of inflammation. These benefits would be particularly evident in women.

Key facts

Study ID
NCT01921010
Run by
Cedars-Sinai Medical Center
People needed
43
Starts
2003-06-01
Expected to finish
2005-06-01
Last updated by the study team
2019-04-23

Who can join

Age: 18 and older, up to 100. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.